Advertisement

Topics

"A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" Drugs and Medication Database

13:47 EST 21st February 2019 | BioPortfolio

Here are the most relevant "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" Drugs and Medications that we have found in our database.

More Information about "A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy" on BioPortfolio

We have published hundreds of A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy news stories on BioPortfolio along with dozens of A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy Clinical Trials and PubMed Articles about A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy Companies in our database. You can also find out about relevant A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy Drugs and Medications on this site too.

Showing "Study Assess Safety Dose Conversion Dose Individualization Duragesic" Drugs and Medications 1–25 of 26

Probably Relevant

Duragesic [janssen pharmaceuticals, inc.]

These highlights do not include all the information needed to use DURAGESIC safely and effectively. See full prescribing information for DURAGESIC. DURAGESIC (Fentanyl Transdermal System) for transdermal administration, CIIInitial U.S. Approval: 1968

Duragesic [janssen pharmaceuticals, inc.]

These highlights do not include all the information needed to use DURAGESICsafely and effectively. See full prescribing information for DURAGESIC. DURAGESIC (fentanyl transdermal system), CII Initial U.S. Approval: 1968

Possibly Relevant

Buprenorphine [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE Transdermal System for transdermal administrati

Buprenorphine [lake erie medical dba quality care products llc]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE Transdermal System for transdermal administrati

Lamotrigine [direct rx]

LAMOTRIGINE

Buprenorphine [lake erie medical dba quality care products llc]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System CIII Initial U.S. Approval:

Exalgo [stat rx usa llc]

These highlights do not include all the information needed to use EXALGO™ safely and effectively. See full prescribing information for EXALGO. EXALGO (hydromorphone HCl) Extended-Release Tablets, CII Initial U.S. Approval: 1984

Ropinirole [trigen laboratories, llc]

These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral use Initi

Requip [glaxosmithkline llc]

These highlights do not include all the information needed to use REQUIP XL safely and effectively. See full prescribing information for REQUIP XL.REQUIP XL (ropinirole) extended-release tablets, for oral useInitial U.S. Approval: 1997

Buprenorphine [rhodes pharmaceuticals l.p.]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System CIII Initial U.S. Approval:

Ropinirole [sandoz inc]

These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral use Initi

Priloxx lp external kit [sircle laboratories llc]

Priloxx LP External Kit

Ropinirole hydrochloride [wockhardt usa llc.]

These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral useInitia

Ropinirole [dr. reddys laboratories limited]

These highlights do not include all the information needed to use ROPINIROLE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for ROPINIROLE EXTENDED-RELEASE TABLETS. ROPINIROLE extended-release tablets, for oral use Initi

Tetrofosmin [anazaohealth corporation]

Tetrofosmin (for the preparation of Tc99m Tetrofosmin injection)

Tetrofosmin [anazaohealth corporation]

Tetrofosmin (for the preparation of Tc99m Tetrofosmin injection)

Halaven [eisai inc.]

These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN.         HALAVEN (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 2010

Methotrexate [thymoorgan gmbh pharmazir & co. k.g]

Methotrexate Injection, USP

Paingo kft [international brand management, llc]

NA

Temozolomide [amerigen pharmaceuticals inc.]

These highlights do not include all the information needed to use TEMOZOLOMIDE safely and effectively. See full prescribing information for TEMOZOLOMIDE. TEMOZOLOMIDE (TEMOZOLOMIDE) CAPSULE for ORAL use. Initial U.S. Approval: 1999

Corlanor [amgen inc]

These highlights do not include all the information needed to use   CORLANOR safely and effectively. See full prescribing information for   CORLANOR . CORLANOR   ( ivabradine ) t ablets , for oral use Initial U.S. Approval: 2015

Venclexta [abbvie inc.]

These highlights do not include all the information needed to use VENCLEXTA safely and effectively. See full prescribing information for VENCLEXTA. VENCLEXTA (venetoclax tablets) for oral use Initial U.S. Approval: 2016

Cuvposa [merz pharmaceuticals, llc]

These highlights do not include all the information needed to use CUVPOSA safely and effectively. See full prescribing information for CUVPOSA. CUVPOSA (glycopyrrolate) oral solution Initial U.S. Approval: 1961

Sulfamethoxazole and trimethoprim [physicians total care, inc.]

Sulfamethoxazole and Trimethoprim Tablets, USP

Ranitidine [unit dose services]

Ranitidine Syrup (Ranitidine Oral Solution, USP)



Advertisement
Quick Search
Advertisement
Advertisement